The balance shifts

The risk of contracting a Clostridium difficile infection following operations for which a "prophylactic" antibiotic is given to prevent infection is 21 times greater now than it was just a decade ago, according to researchers from the University of Sherbrooke in Canada. They report their findings in the June 15 issue of Clinical Infectious Diseases, currently available online.

Surgical operations that have been associated with severe infections, such as open heart surgeries and prosthetic implants, are often accompanied by the simultaneous administration of antibiotics, a strategy which has successfully reduced the number of infections. A consequence of this antimicrobial therapy is a modification in normal flora of the human intestine. In this altered environment, a bacterium named Clostridium difficile can thrive. An infection with C. difficile can cause severe diarrhea, occasionally leading to death.

Historically, the benefits of preventing surgical site infections have outweighed the relatively minor risk of C. difficile infections. However, in 2000 a hypervirulent strain of C. difficile emerged, leading to a dramatic increase in the number of infections and in the severity of those infections.

Researchers from the University of Sherbrooke recently completed a study that calculated the risk of contracting a C. difficile infection when the sole antibiotic given was prophylaxis accompanying surgery and compared the current risk with the risk from a period before the emergence of the hypervirulent strain. They found a 21-fold increase in the risk, from 0.07 percent of patients to 1.5 percent. Of the 40 patients who developed a C. difficile infection after peri-operative antibiotic prophylaxis, 5 either died or developed septic shock. Cefoxitin was most likely to be associated with the contraction of a C. difficile infection.

Because the outcomes of C. difficile infections can be severe, the authors suggested that cases be individually evaluated and if the purpose of the antibiotic therapy is only to prevent infrequent or relatively benign infections, then the risks may outweigh benefits. This may be particularly important with elderly patients, who fare worse with C. difficile infections than do younger people.

In addition, the study’s lead author, Louis Valiquette, MD, MSc, suggested that surgical antibiotic prophylaxis should be used for the shortest duration possible to minimize the risk of C. difficile infection. This would also produce collateral benefits of decreasing cost, reducing microbial-related side effects, and slowing the development of bacterial resistance.

Source: Infectious Diseases Society of America

Related stories:

MRSA in hospital intensive care -- what's growing where?
Researchers are finding out which bugs grow in intensive care units to develop a novel sampling regime that would indicate the threat of MRSA and other superbugs in the environment, scientists heard today at the Society for General Microbiology’s 162nd meeting being held this week at the Edinburgh International Conference Centre.
If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands
We've all heard people say 'I won't kiss you, I've got a cold'. But a report just published warns that we may be far more at risk of passing on an infection by shaking someone's hand than in sharing a kiss.
Dangerous diarrheal bacterium found on asymptomatic patients
The bacterium that causes a highly contagious and sometimes deadly form of diarrhea is frequently carried by persons who do not have any of the disease symptoms, according to a study in the Oct. 15 issue of Clinical Infectious Diseases, now available online. These findings have dramatic implications for health care workers who have customarily treated and isolated only those patients who exhibit symptoms.
Multi-tasking maggots in superbug showdown
Scientists at Swansea University (Wales, UK) have discovered a new type of antibiotic in maggot secretions that can tackle up to 12 different strains of MRSA, as well as E. coli and C. difficile. The research was funded by leading charity Action Medical Research, with support from the Rosetrees Trust.
Breakthrough in the fight against deadly superbug
(PhysOrg.com) -- The week the government's chief medical officer for England, Sir Liam Donaldson, has announced that the NHS aims to create immunisation against two of the most common superbugs, MRSA and Clostridium difficile, within the next decade. But a research team led by University of Sunderland scientists has made a major breakthrough in the fight against a deadly hospital infection which kills tens of thousands of people every year, and it will be available within the next year.
Online courses boost infection control skills that could prove vital in a pandemic
Online courses are helping staff to develop the skills they need to tackle hospital-acquired infections, such as MRSA and C.difficile, and this expertise could also prove vital in a pandemic, according to a study published in the latest issue of the UK-based Journal of Advanced Nursing.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.
Less hype and more research needed into new 'superbug,' say experts
Recent tabloid hype over the "newly emerging superbug", Stenotrophomonas maltophilia, is misplaced, say experts in this week's issue of the BMJ.

News discussion:

Medicine & Health news